Skip to Content

par 544 (Ranitidine 150 mg)

Pill imprint par 544 has been identified as Ranitidine hydrochloride 150 mg.

Ranitidine is used in the treatment of gerd; erosive esophagitis; gastric ulcer maintenance treatment; duodenal ulcer; zollinger-ellison syndrome (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ranitidine hydrochloride 150 mg par 544
Ranitidine hydrochloride 150 mg par 544  Front
Ranitidine hydrochloride 150 mg par 544  Back
Ranitidine hydrochloride 150 mg par 544
Ranitidine hydrochloride
par 544
150 mg
9.00 mm
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Par Pharmaceutical Inc.
National Drug Code (NDC):
Inactive Ingredients:
FD&C Yellow No. 6
lactose monohydrate
magnesium stearate
microcrystalline cellulose
pregelatinized corn starch
titanium dioxide
triethyl citrate
ferric oxide yellow
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
62584-0252 Amerisource Health Services
63739-0266 McKesson Packaging Services
66267-0188 Nucare Pharmaceuticals Inc (repackager)
67544-0146 Prepak Systems Inc (repackager)
21695-0109 Rebel Distributors Corp (repackager)
68258-1072 Dispensing Solutions Inc. (repackager)
68115-0787 Dispensexpress Inc (repackager)
49999-0043 Lake Erie Medical and Surgical Supply (repackager)
68115-0314 Dispensexpress Inc (repackager)
18837-0133 Innoviant Pharmacy Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.